Streetbeat News

Partnerships

FOUR

Shift4 (NYSE:FOUR) has been chosen as the official point-of-sale systems partner for the New York Yankees, providing its integrated payments technology for concessions and retail transactions at Yankee Stadium and George M. Steinbrenner Field. This partnership aims to enhance the transaction experience for guests with Shift4's end-to-end commerce solution, which includes hardware, software, and third-party integrations tailored for high-volume venues.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 1:05 pm

SNN

Smith+Nephew (NYSE:SNN) has entered into a Master Cooperative Research and Development Agreement (CRADA) with the U.S. Army Institute of Surgical Research (USAISR). This is the first master agreement of its kind between USAISR and a leading medical technology company, covering all of Smith+Nephew's business units. The agreement aims to facilitate collaborative research efforts, streamline the research agreement process, and leverage both parties' infrastructure and expertise to support innovation in combat casualty care.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 1:03 pm

FMST

Foremost Lithium Resource & Technology Ltd (NASDAQ:FMST) has submitted a $10 million proposal to the Government of Canada's Critical Mineral Infrastructure Fund to enhance the lithium transport corridor in Manitoba's Snow Lake region. This initiative aims to build and improve roads for the transportation of lithium, gold, nickel, and timber, supporting economic growth and sustainable development. FMST shares dropped 2.95% to $2.96 in premarket trading.

Portfolio Pulse from Anusuya Lahiri

February 28, 2024 | 1:01 pm

NEXN

Nexxen International Ltd. has settled an agreement and initiated a three-year strategic partnership with Alphonso Inc. and LG Electronics, focusing on advertising technology, particularly in video and Connected TV. Financial details were not disclosed.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 12:31 pm

DNA

bit.bio has been announced as the inaugural partner of Ginkgo Bioworks' new technology network. This partnership will allow bit.bio's ioCells portfolio of human cells, designed for research and drug discovery, to be integrated into Ginkgo's platform ecosystem.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 12:15 pm

ACIW

ACI Worldwide, a leading global provider of real-time digital payment software and solutions, has announced the extension of its longstanding partnership with Kuvasz Solutions. This collaboration aims to enhance and expand the range of payment solutions offered to their clients, leveraging both companies' strengths to innovate and meet the evolving needs of the digital payments market.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 12:14 pm

MAN

WIT

Wipro has successfully completed the migration of Manpower Group's largest data center in Europe to Microsoft Azure, marking a significant achievement in cloud services and infrastructure management.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 11:50 am

FSR

Fisker has announced two new dealer partnerships to expand its presence in New York State, Florida, and Indiana. These partnerships aim to increase the availability and accessibility of Fisker's electric vehicles (EVs) in these regions, supporting the company's growth strategy in the competitive EV market.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 11:38 am

FSK

Fisker has expanded its dealership network by signing agreements with two new dealer partners, leading to the opening of three new locations in New York State, Florida, and Indiana. This expansion is part of Fisker's strategy to increase its presence and accessibility in key markets across the United States.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 11:31 am

VTRS

Viatris Inc. (NASDAQ:VTRS) has entered into a global partnership with Idorsia for the development and commercialization of selatogrel, a treatment for acute myocardial infarction (AMI), and cenerimod, a potential treatment for systemic lupus erythematosus (SLE). Viatris will receive exclusive global rights to these assets, with Idorsia receiving an upfront payment of $350 million, along with potential milestone payments and royalties. Both companies will share development costs, and the deal includes rights of first refusal and negotiation for Viatris on future Idorsia assets.

Portfolio Pulse from Nabaparna Bhattacharya

February 28, 2024 | 10:20 am